VA/DoD CLINICAL PRACTICE GUIDELINE FOR OPIOID THERAPY FOR CHRONIC PAIN

VA/DoD Clinical Practice Guideline for Opioid Therapy for Chronic Pain
#
Recommendation
3. For patients currently on long-term opioid therapy, we
recommend ongoing risk mitigation strategies (see
Recommendations 7-9), assessment for opioid use disorder,
and consideration for tapering when risks exceed benefits
(see Recommendation 14).
4. a) We recommend against long-term opioid therapy for
pain in patients with untreated substance use disorder.
b) For patients currently on long-term opioid therapy with
evidence of untreated substance use disorder, we
recommend close monitoring, including engagement in
substance use disorder treatment, and discontinuation
of opioid therapy for pain with appropriate tapering (see
Recommendations 15 and 18).
5. We recommend against the concurrent use of
benzodiazepines and opioids.
Note: For patients currently on long-term opioid therapy and
benzodiazepines, consider tapering one or both when risks
exceed benefits and obtaining specialty consultation as
appropriate (see Recommendation 15 and VA/DoD
Substance Use Disorders CPG).
6. a) We recommend against long-term opioid therapy for
patients less than 30 years of age secondary to higher
risk of opioid use disorder and overdose.
b) For patients less than 30 years of age currently on longterm
opioid therapy, we recommend close monitoring
and consideration for tapering when risks exceed
benefits (see Recommendations 15 and 18).
2010
Grade 14 Evidence 15 Strength of
Recommendation 16
None [86-89,255]
Strong for
Additional References:
[132]
None [59,61,66,86,87] a) Strong against
N/A [66]
Additional References:
[90,91]
None [58,59,62,86-88,92,94]
Additional References:
[93,95-98]
b) Strong for
Strong against
a) Strong against
b) Strong for
Recommendation
Category 17
Reviewed, Newreplaced
Reviewed, Amended
Reviewed, Newadded
Reviewed, Newreplaced
February 2017 Page 128 of 192